Labopharm To Pursue FDA Approval For Once-Daily Tramadol
This article was originally published in The Pink Sheet Daily
Executive Summary
As part of Ortho-McNeil's partnership with Biovail for extended release tramadol, Ortho is relinquishing exclusivity on the once-daily formulation - opening the way for Labopharm to pursue approval of its own product